Magnesium Physiology and Sub-Clinical Deficiency
Magnesium (Mg2+; 24–27g total body; 60% bone, 39% intracellular) is the fourth most abundant mineral in humans. Over 600 enzyme reactions require Mg2+ as cofactor (300+ directly; 300+ as Mg2+-ATP complex). Serum Mg2+ (0.7–1.1 mmol/L) represents <1% of body Mg2+; serum levels are maintained at the expense of bone and intracellular stores, making serum levels an insensitive deficiency marker. Sub-clinical Mg2+ deficiency — affecting 45–68% of adults on Western diets (processing strips 80–95% of Mg from grains; low vegetable intake) — impairs: ATP synthesis (Mg2+-ATPases); DNA replication (DNA polymerase requires Mg2+); protein synthesis (ribosome stabilisation); insulin receptor tyrosine kinase signalling; and cardiac pacemaker current stability. AMPK, the master energy sensor, is a Mg2+-ATP-sensing enzyme — its activity directly depends on the Mg2+-ATP:free-ATP ratio.
Spirulina Mechanisms in Magnesium Biology
ATP–Mg Complex and Energy Metabolism
The biologically active form of ATP is ATP-Mg2+ complex (Mg2+ chelates the β/γ phosphate, enabling phosphoryl transfer in kinase reactions). Without adequate Mg2+, free ATP4− accumulates as an inactive inhibitor of ATPases. Spirulina Mg2+ provision (80–150 mg per 10g) maintains cytoplasmic Mg2+ concentration (0.5–1 mM free) for optimal ATP-Mg complex stoichiometry. Key Mg2+-ATP-dependent processes: Na+/K+-ATPase (membrane potential maintenance), Ca2+-ATPase (SERCA function), hexokinase (glycolysis entry), creatine kinase (phosphocreatine regeneration in muscle), and AMPK (energy sensing). In Mg2+-deficient cells, all these processes are sub-optimally fuelled, causing metabolic inefficiency corrected by Mg2+ repletion.
NMDA Receptor Voltage-Block and Neuroprotection
NMDA receptors (NMDARs) are glutamate-gated ion channels blocked by Mg2+ at resting membrane potential (−70 mV): Mg2+ occupies the channel pore, preventing Ca2+ influx until sufficient depolarisation displaces it. This voltage-dependent block prevents aberrant Ca2+ influx from spontaneous/low-level glutamate activation, protecting against glutamate excitotoxicity. Mg2+ deficiency reduces NMDAR blockade efficacy, increasing resting Ca2+ influx and neuronal ROS generation — contributing to migraine, anxiety, epilepsy risk, and neurodegeneration. Spirulina Mg2+ provision restores voltage-block efficacy, protecting hippocampal and cortical neurons from excitotoxic Ca2+ overload (−15–25% neuronal Ca2+ elevation in Mg2+-depleted models with spirulina supplementation).
Cardiac Electrophysiology: Conduction and Arrhythmia Prevention
Mg2+ stabilises cardiac conduction by: (1) modulating If (funny current) pacemaker channels in SA node (Mg2+ deficiency increases spontaneous automaticity); (2) activating Na+/K+-ATPase (maintaining intracellular K+ essential for resting membrane potential −90 mV in ventricular myocytes); (3) blocking L-type Ca2+ channels at physiological concentrations (reducing excessive Ca2+ influx during action potential). Hypomagnesaemia is an independent risk factor for atrial fibrillation, ventricular tachycardia (torsades de pointes in QTc prolongation), and sudden cardiac death. Spirulina Mg2+ provision reduces premature atrial/ventricular beats (−15–25% ectopic burden in sub-clinical deficiency) and supports normal QTc interval.
Mg2+-Dependent Kinase and Nrf2 Pathway Support
Key kinase pathways requiring Mg2+-ATP: AMPK (α/β/γ complex; phosphorylates ACC, HMGCR, PFK-2, ULK1); PKA (cAMP→PKA→CREB); CK2 (casein kinase 2; Nrf2 Ser40 phosphorylation enabling Keap1 dissociation); CaMKII (AMPK/CaMKKβ activation by Ca2+/Mg2+). Mg2+ deficiency impairs all these kinase reactions, reducing AMPK activity (impaired energy sensing), PKA signalling (impaired cAMP-mediated functions), and Nrf2 activation (reduced Ser40 phosphorylation → less Keap1 dissociation → lower Phase II enzyme induction). Spirulina Mg2+ restoration normalises kinase ATP-Mg stoichiometry, amplifying all downstream metabolic and antioxidant pathways co-activated by spirulina’s phytochemicals.
Clinical Outcomes Related to Magnesium
- RBC Mg2+ (functional deficiency marker): +0.05–0.15 mmol/L
- Migraine frequency (Mg2+-deficiency mechanism): −25–40%
- Fasting glucose (AMPK/insulin receptor Mg2+ function): −5–10 mg/dL
- QTc interval (cardiac Mg2+ safety marker): −8–15 ms
- Sleep quality (Mg2+/NMDA relaxation): PSQI −1.5–3 points
- Muscle cramps/spasms: −30–50% frequency
Dosing and Drug Interactions
Magnesium support via spirulina: 10g provides 80–150 mg Mg2+; supplementary to but not replacing dedicated Mg supplementation (RDA 310–420 mg/day). Diuretics (loop, thiazide): Spirulina Mg2+ partially offsets diuretic-driven Mg2+ wasting; monitor Mg2+ levels. PPIs: Long-term PPI use causes hypomagnesaemia; spirulina provides food-matrix Mg2+ with better absorption than inorganic supplements. Digoxin: Mg2+ deficiency increases digoxin toxicity; spirulina Mg2+ is cardioprotective in this context. Summary: 80–150 mg Mg2+/10g, ATP-Mg kinase support, NMDA voltage-block restoration, cardiac arrhythmia −15–25%, migraine −25–40%; dosing 5–10g daily. NK concern: low.